Trade Summary

1 week ago, New Enterprise Associates 17, L.P., serving as 10% owner at Spyglass Pharma, Inc. (SGP), purchased 937,500 shares at $16.00 per share, for a total transaction value of $15,000,000.00. Following this transaction, New Enterprise Associates 17, L.P. now holds 6,035,038 shares of SGP.

This purchase represents a 18.00% increase in New Enterprise Associates 17, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 11, 2026, 2 days after the trade was made.